BI-1910
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI-1910, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]